Healthcare organizations, prepare for more cyberattacks: On the back of Hive’s shutdown, we recap what we saw in 2022, and highlight what to watch out for in 2023.

How chatbots can increase patient engagement: A research study by AllianceChicago shows how personalized messages boosted well-child visits and immunizations among minority patients.

Is Amazon’s RxPass too good to be true? We look at the pros and cons of the new program, which offers some generic prescriptions for a flat $5 per month.

Healthcare interoperability state of play? Health systems are gearing up to spend more on connected health solutions in 2023. We explore the factors propelling this shift.

Doctors say digital tools are vital to patient engagement: We unpack recent research on physicians’ uptake of digital tools and the patient expectations that are driving the shift.

Transcarent gives members virtual access to medical second opinions: The company is hoping that its tie-up with Cleveland Clinic will generate savings for employer customers.

Hard times ahead for D2C healthcare marketers: We unpack Rock Health’s 2022 investment report and what the dropoff in funding means for consumer-focused healthcare brands.

Kroger Health touts in-store health services: A new brand campaign takes aim at retail health rivals while boosting its retail media network.

Big players are eyeing integration and interoperability: We unpack some developments from this year’s CES and where we see the market moving this year.

Which companies are and aren’t threatening health systems? Incumbent providers should be keeping tabs on retail and tech conglomerates instead of telehealth-focused players.

How healthcare providers will approach telehealth in 2023: Here’s the current status of health systems’ and physician practices’ virtual care programs and how they plan to improve this year.

Telehealth apps are violating consumer trust: We unpack data from STAT’s recent report on direct-to-consumer telehealth companies’ shady data-sharing practices that could eroder consumers’ trust in digital health.

What were Big Tech healthcare players up to in 2022? We review the most prominent healthcare developments from Big Tech entities in the past year and preview what’s on deck for 2023.

One healthcare prediction we got wrong for 2022: We look back over the year to see what didn’t happen, per our 2021 prognoses.

Consumers want a one-stop-shop health management platform: But will diverse healthcare stakeholders band together to bring such a solution to market?

Reimbursement barriers impede remote patient monitoring growth: Health systems must prove their remote monitoring programs are effective—especially if they want state Medicaid programs to provide coverage.

Big retail players jockey for healthcare positioning: We look back at noteworthy advancements made by retail health companies this year and how the top players stack up going into 2023.

Healthcare predictions we got right for 2022: As we expected, the lines between healthcare and retail blurred, and consumers cozied up with connected health devices. We detail other predictions we got right for the year.

Disruption in the digital pharmacy space: We unpack developments with Medly, NowRx, and Mark Cuban Cost Plus Drugs and look ahead to what’s in store for 2023.

Easy access and short wait times drive consumers to telehealth: But virtual care providers will need to stay on top of their game to keep patients from going elsewhere.